A valid mouse model of AGRIN-associated congenital myasthenic syndrome
Open Access
- 1 September 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 20 (23), 4617-4633
- https://doi.org/10.1093/hmg/ddr396
Abstract
Congenital myasthenic syndromes (CMS) are inherited diseases affecting the neuromuscular junction (NMJ). Mutations in AGRIN (AGRN) and other genes in the AGRIN signaling pathway cause CMS, and gene targeting studies in mice confirm the importance of this pathway for NMJ formation. However, these mouse mutations are complete loss-of-function alleles that result in an embryonic failure of NMJ formation, and homozygous mice do not survive postpartum. Therefore, mouse models of AGRIN-related CMS that would allow preclinical testing or studies of postnatal disease progression are lacking. Using chemical mutagenesis in mice, we identified a point mutation in Agrn that results in a partial loss-of-function allele, creating a valid model of CMS. The mutation changes phenylalanine 1061 to serine in the SEA domain of AGRIN, a poorly characterized motif shared by other extracellular proteoglycans. NMJs in homozygous mice progressively degrade postnataly. Severity differs with genetic background, in different muscles, and in different regions within a muscle in a pattern matching mouse models of motor neuron disease. Mutant NMJs have decreased acetylcholine receptor density and an increased subsynaptic reticulum, evident by electron microscopy. Synapses eventually denervate and the muscles atrophy. Molecularly, several factors contribute to the partial loss of AGRIN's function. The mutant protein is found at NMJs, but is processed differently than wild-type, with decreased glycosylation, changes in sensitivity to the protease neurotrypsin and other proteolysis, and less efficient externalization and secretion. Therefore, the Agrn point mutation is a model for CMS caused by Agrn mutations and potentially other related neuromuscular diseases.Keywords
This publication has 69 references indexed in Scilit:
- Induction of filopodia-like protrusions by transmembrane agrin: Role of agrin glycosaminoglycan chains and Rho-family GTPasesExperimental Cell Research, 2010
- Identification of an Agrin Mutation that Causes Congenital Myasthenia and Affects Synapse FunctionAmerican Journal of Human Genetics, 2009
- LRP4 Serves as a Coreceptor of AgrinNeuron, 2008
- Lrp4 Is a Receptor for Agrin and Forms a Complex with MuSKCell, 2008
- Defects in eye development in transgenic mice overexpressing the heparan sulfate proteoglycan agrinDevelopmental Biology, 2007
- Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucinNature Structural & Molecular Biology, 2005
- Defective Neuromuscular Synaptogenesis in Agrin-Deficient Mutant MiceCell, 1996
- The Receptor Tyrosine Kinase MuSK Is Required for Neuromuscular Junction Formation In VivoCell, 1996
- The ability of agrin to cluster AChRs depends on alternative splicing and on cell surface proteoglycansNeuron, 1993
- RNA splicing regulates agrin-mediated acetylcholine receptor clustering activity on cultured myotubesNeuron, 1992